Differential ConA-enriched urinary proteome in rat experimental glomerular diseases

Glomerular diseases are leading causes of end-stage renal diseases worldwide. They are considered to be consequences of injury primarily to the three types of glomerular cells. Differential diagnosis typically relies on invasive biopsy findings. We expected that injuries of different glomerular cells would cause different changes in urinary proteome. The goal of this study was to identify differential urinary proteins distinguishing between injuries of different glomerular cells before significant histopathologic changes. Adriamycin nephropathy and Thy1.1 glomerulonephritis were employed as models with different primary impaired cells. ConA-enriched urinary glycoproteome on day3 were profiled by gel-free shotgun tandem mass spectrometry, and compared with self-healthy controls to identify differential urinary proteins for each model. By comparing the changes of the differential proteins between these two models, we identified 39 proteins with different directions of changes, which may potentially be useful in differentiation; and 7 proteins with the same direction of changes, which may be potential indicators of early renal damage. These differential proteins were of several origins: plasma proteins, proteins with urine or kidney specificity, proteins without tissue-specificity (mainly inflammatory mediators) etc. Our results may help better understand the effects of injuries of different glomerular cells at the initial stage, and lead to the discovery of novel early diagnostic markers for human focal segmental glomerulosclerosis (FSGS) and mesangioproliferative glomerulonephritis (MsPGN) which have the same primary impaired cells with adriamycin nephropathy and Thy1.1 glomerulonephritis, respectively.     

病原菌诱导型启动子顺式作用元件及其互作的转录因子

启动子是位于基因5′端上游的一段DNA序列, 负责调控基因的转录。与植物抗病相关基因的启动子区含有能针对病原菌胁迫做出应答的顺式作用元件, 这些顺式作用元件通过与转录因子特异性结合, 进而增强抗病基因的转录表达, 提高植物的抗病性。该文主要综述了病原菌诱导型启动子相关顺式作用元件及与这些元件互作的转录因子, 特别对一类特殊的转录因子--病原菌TAL效应子与植物靶基因启动子之间的相互作用机制进行了阐述, 并对其应用前景进行了展望。     

一种经microRNA敲低PD-1的新型慢病毒载体在CAR-T细胞中的应用

本研究将microRNA插入EF1α启动子的内含子中,构建携带沉默PD-1基因的miRNA的新型慢病毒载体,并将其应用于CAR-T细胞。通过流式细胞术检测慢病毒载体转导效率和PD-1沉默效率;Westernblotting检测PD-1蛋白表达差异;荧光定量PCR检测microRNA相对表达情况;荧光素酶生物发光法和流式细胞术检测CAR-T细胞的能力。结果显示与U6转录microRNA的载体相比较,将microRNA插入到EF1-α内含子中的病毒载体转导效率更显著,对PD-1的敲低效率均达90%以上,且Westernblotting结果验证了PD-1的敲低效果。另外通过荧光定量PCR,可显示出转导该新型慢病毒载体的Jurkat细胞内microRNA的相对表达量。荧光素酶生物发光法证实了CAR-T细胞针对靶细胞的特异杀伤性,流式细胞术结果表明沉默PD-1的CAR-T细胞相较于正常CAR-T细胞显示出更强的特异性杀伤能力。本研究成功构建了经microRNA敲低PD-1的新型慢病毒载体并验证了其转导效率的优越性,以及基于此载体表达的microRNA可高效地沉默PD-1;且应用此载体的CAR-T细胞能发挥更强的杀伤活性,从而为后续该CAR-T细胞治疗表达PD-L1的肿瘤奠定基础。     

微贮用植物乳杆菌固定化菌剂的制备

乳酸菌与纤维素降解菌因其可防止微贮饲料酸败、增加秸秆饲料的营养价值等优点,在秸秆微贮过程中起重要作用。但由于乳酸菌的繁殖会抑制纤维素降解菌的活性,如何实现微贮过程中两种微生物分时发挥功能是解决上述问题的关键。文中利用固定化技术将乳酸菌制备成含有玉米秸秆粉的固定化菌剂以达到缓释的目的。首先制作固定化空白小球得出复合固定化载体成球的最佳浓度,利用玉米芯吸附植物乳杆菌S1得到复合固定化载体,以对S1的包埋率、成球效果等为指标,通过对比两种固定化方法 (包埋法与包埋-交联法),得到固定化植物乳杆菌S1的最佳条件。研究表明,使用6%PVA+0.4%SA+0.3%CMC-Na进行包埋-交联时成球效果最好,使用1.2%SA+0.5%CMC-Na进行直接包埋时成球效果最好。通过对比5种固定化工艺,将1.2%SA+0.5%CMC-Na和吸附玉米粉组成的固定化载体混合物逐滴滴入4%氯化钙中直接包埋24 h得到的固定化小球其机械强度以及包埋率均优于其他工艺。因此,利用玉米芯吸附-海藻酸钠包埋的方法可以有效提高植物乳杆菌包埋效率,为使用固定化技术制备微贮饲料菌剂奠定基础。     

Solvent-Mediated Synthesis of Functional Powder Materials from Deep Eutectic Solvents for Energy Storage and Conversion: A Review

Developing advanced electrochemical energy storage and conversion (ESC) technologies based on renewable clean energy can alleviate severe global environmental pollution and energy crisis. The efficient preparation of functional electrode materials via a simple, green, and safe synthesis process is the key to the commercial feasibility of these ESC systems. Deep eutectic solvents (DESs) with easy-tunable solvent properties and recyclable features have emerged as novel solvent systems for designing and synthesizing various functional powder materials for ESC devices. In this paper, the application of DESs in the synthesis of energy-related functional powder materials is systematically reviewed. After briefly introducing the classification and synthesis of DESs, their critical roles in synthesizing powder materials are discussed. Then, the recent advances of DES-derived powder materials in ESC, including batteries, fuel cells, supercapacitors, and water splitting, are described in detail from the perspective of preparation-structure-activity. Finally, some challenges and development directions of the DESs-mediated synthesis of powder materials with high electrochemical performance for ESC applications are outlined.     

High-Areal-Capacity and Long-Cycle-Life All-Solid-State Lithium-Metal Battery by Mixed-Conduction Interface Layer

The rapid growth of lithium dendrites has seriously hindered the development and practical application of high-energy-density all-solid-state lithium metal batteries (ASSLMBs). Herein, a soft carbon (SC)-nano Li_6.4La₃Zr_1.4Ta_0.6O₁₂ (LLZTO) (with high ionic conductivity and diffusion coefficient) mixed ionic and electronic conducting interface layer is designed to promote the rapid migration of Li⁺ at the interfacial layer, induce the uniform deposition of lithium metal on nanoscale (nano) LLZTO ion-conducting network inside the interface layer, effectively suppress the growth of lithium dendrites, and significantly improve the electrochemical performance of ASSLMBs. LiZrO₂@LiCoO₂(LZO@LCO)/Li₆PS₅Cl(LPSCl)-nano LLZTO/Li ASSLMB achieves high current density (12.5 mA cm⁻²), ultra-high areal capacity (15 mAh cm⁻², corresponding to LZO@LCO mass loadings of 111.11 mg cm⁻²), and ultra-long cycle life (20 000 cycles). Therefore, the introduction of SC-nano LLZTO mixed conducting interface layer can greatly improve the interfacial stability between solid-state electrolyte (SSE) and lithium metal anode to enable dendrite-free ASSLMBs.     

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Mutations of the RAS oncogene are found in around 30% of all human cancers yet direct targeting of RAS is still considered clinically impractical except for the KRAS^G12C mutant. Here we report that RAS-ON (RASON), a novel protein encoded by the long intergenic non-protein coding RNA 00673 (LINC00673), is a positive regulator of oncogenic RAS signaling. RASON is aberrantly overexpressed in pancreatic ductal adenocarcinoma (PDAC) patients, and it promotes proliferation of human PDAC cell lines in vitro and tumor growth in vivo. CRISPR/Cas9-mediated knockout of Rason in mouse embryonic fibroblasts inhibits KRAS-mediated tumor transformation. Genetic deletion of Rason abolishes oncogenic KRAS-driven pancreatic and lung cancer tumorigenesis in LSL-Kras^G12D; Trp53^R172H/+ mice. Mechanistically, RASON directly binds to KRAS^G12D/V and inhibits both intrinsic and GTPase activating protein (GAP)-mediated GTP hydrolysis, thus sustaining KRAS^G12D/V in the GTP-bound hyperactive state. Therapeutically, deprivation of RASON sensitizes KRAS mutant pancreatic cancer cells and patient-derived organoids to EGFR inhibitors. Our findings identify RASON as a critical regulator of oncogenic KRAS signaling and a promising therapeutic target for KRAS mutant cancers.Subject terms: Gastrointestinal cancer, Cancer therapy